About Life Science Angels
Life Science Angels was established in 2005 as a non-profit angel network based in Sunnyvale, United States. Investments are directed toward companies in biotechnology, diagnostics, medical devices, and biopharma sectors. Nearly 50 million has been committed to over 40 companies since inception. Decisions on investments are handled individually or through majority vote, with commitments reaching up to 10 million per deal.
- Headquarter Sunnyvale, United States
-
Sectors
Financial Services
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Life Science Angels
Unlock access to complete
Unlock access to complete
Funding Insights of Life Science Angels
Investments & Acquisitions by Life Science Angels
Financial Statements - Life Science Angels
Life Science Angels Comparisons
Competitors of Life Science Angels
Latest news on Life Science Angels
Frequently Asked Questions about Life Science Angels
Life Science Angels is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Life Science Angels was established in 2005 as a non-profit angel network based in Sunnyvale, United States. Investments are directed toward companies in biotechnology, diagnostics, medical devices, and biopharma sectors. Nearly 50 million has been committed to over 40 companies since inception. Decisions on investments are handled individually or through majority vote, with commitments reaching up to 10 million per deal.